Published

13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Biological Psychiatry
Date: 2025-04-09
Source: OpenAlex
DOI: 10.1016/j.biopsych.2025.02.250
PubMed: Unavailable

Authors

Danielle Bukovsky Aron Amaev Jianmeng Song Edgardo Torres Carmona S. Lauren Kyte Fumihiko Ueno Vincenzo De Luca Christopher R. Bowie Alastair J. Flint Muhammad Ishrat Husain Ariel Graff-Guerrero Philip Gerretsen

Watch author

Derived topics and classifications

psilocybin Brain Imaging Receptor Pharmacology Aging Older Adults Safety Toxicity Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study2025-04-09

Related papers

Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20